CAS 2022_A_9246 Shashank J. Rai vs INADA

CAS 2022/A/9246 Shashank J. Rai v. National Anti-Doping Agency, India

Related case:

ADDPI 2022_216 INADA vs Shashank J. Ray
October 13, 2022

On 13 October 2022 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 4 year period of ineligibility on the basketball player Shashank J. Ray after he tested positive for the prohibited substance 19-norandrosterone (Nandrolone).

Hereafter in November 2022 the Athlete appealed the ADDPI decision with the Court of Arbitration for Sport (CAS). The Athlete asserted that his appeal is admissible and that CAS has jurisdiction because he is an International Level Athlete.

INADA denied that the Athlete is an International Level Athtlete and requested the Panel to dismiss this appeal. INADA contended that the Appealed Decision should have been addressed to the Anti-Doping Appeal Panel of India (ADAPI).

In view of the evidence the Sole Arbitrator agrees with INADA's submissions and concludes that the Athlete's appeal must be rejected.

Therefore the Court of Arbitration for Sport decides on 17 July 2023 that:

1.) The Court of Arbitration for Sport has no jurisdiction to decide upon the appeal brought by Mr. Shashank J Rai on 2 November 2022 against the decision of the Anti-Doping Disciplinary Panel of the National Anti-Doping Agency of India dated 11 October 2022.

2.) (…).

3.) (…).

4.) All other motions or prayers for relief are dismissed.

Original document

Parameters

Legal Source
CAS Appeal Awards
Date
17 July 2023
Arbitrator
Rombach, Annett
Original Source
Court of Arbitration for Sport (CAS)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Absence of jurisdiction
Case law / jurisprudence
Interim / preliminary / partial award or decision
Rules & regulations International Sports Federations
Sole Arbitrator
Sport/IFs
Basketball (FIBA) - International Basketball Federation
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
Roma, Italia: Laboratorio Antidoping FMSI
Analytical aspects
B sample analysis
Mass spectrometry analysis
Doping classes
S1. Anabolic Agents
Substances
19-norandrosterone
Nandrolone (19-nortestosterone)
Document type
Pdf file
Date generated
6 June 2024
Date of last modification
11 July 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin